Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sub-lobectomy Versus Lobectomy in IIA-IIIB Non-small-cell Lung Cancer After Neoadjuvant Immunochemotherapy: a Multicentre, Open-label, Randomised, Controlled, Non-inferiority Trial

NCT07612722 is registered in ClinicalTrials.gov with Wen-zhao ZHONG as lead sponsor.

NCT NCT07612722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07612722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sub-lobectomy Versus Lobectomy in IIA-IIIB Non-small-cell Lung Cancer After Neoadjuvant Immunochemotherapy: a Multicentre, Open-label, Randomised, Controlled, Non-inferiority Trial
Lead sponsor
Wen-zhao ZHONG
Phase
Not applicable
Overall status
Recruiting
Start date
May 18, 2026
Completion date
May 31, 2034
Enrollment
585 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc